Bayesian Analysis of Cancer Mortality Rates from Different Types and their Relative Occurrences by Delcroix, Sophie M.
Worcester Polytechnic Institute
Digital WPI
Masters Theses (All Theses, All Years) Electronic Theses and Dissertations
1999-12-14
Bayesian Analysis of Cancer Mortality Rates from
Different Types and their Relative Occurrences
Sophie M. Delcroix
Worcester Polytechnic Institute
Follow this and additional works at: https://digitalcommons.wpi.edu/etd-theses
This thesis is brought to you for free and open access by Digital WPI. It has been accepted for inclusion in Masters Theses (All Theses, All Years) by an
authorized administrator of Digital WPI. For more information, please contact wpi-etd@wpi.edu.
Repository Citation
Delcroix, Sophie M., "Bayesian Analysis of Cancer Mortality Rates from Different Types and their Relative Occurrences" (1999). Masters
Theses (All Theses, All Years). 1114.
https://digitalcommons.wpi.edu/etd-theses/1114
 
 
 
BAYESIAN ANALYSIS OF CANCER MORTALITY RATES FROM 
DIFFERENT TYPES AND THEIR RELATIVE OCCURENCES 
 
 
by 
Sophie M. Delcroix 
A Thesis 
Submitted to the Faculty  
of the 
WORCESTER POLYTECHNIC INSTITUTE 
In partial fulfillment of the requirements for the 
Degree of Master of Science 
in 
Applied Statistics 
February 2000 
 
 
 
 
 
 
 
 
APPROVED: 
 
Dr. Balgobin Nandram, Thesis Advisor 
 
Dr. Hyunjoong Kim, Co-Advisor 
 
Dr. Homer Walker, Head of Department 
ABSTRACT 
 
We analyze mortality data from prostate, colon, lung, and all other types (called other 
cancer) to obtain age specific and age adjusted mortality rates for white males in the U.S.  
A related problem is to estimate the relative occurrences of these four types of cancer.  
 
In the recent Atlas of the Unite States Mortality (1996) each type of cancer was 
analyzed individually. The difficulty in doing so is that there are many small areas with 
zero deaths.  We conjecture that simultaneous analyses might help to overcome this 
problem, and at the same time to estimate the relative occurrences. 
 
We start with a Poisson model for the deaths, which produces a likelihood function 
that separates into two parts: a Poisson likelihood for the rates and a multinomial 
likelihood for the relative occurrences. These permit the use of a standard Poisson 
regression model on age as in Nandram, Sedransk and Pickle (1999), and the novelty is a 
multivariate logic model on the relative occurrences in which per capita income, the 
percent of people below poverty level, education (percent of people with four years of 
college) and two criteria pollutants, EPAPM25 and EPASO2, are used as covariates.  
 
We fitted the models using Markov chain Monte Carlo methods. We used one of the 
models to present maps of occurrences and rates for the four types. An alternative model 
did not work well because it provides the same pattern by age and disease.  
 
We found that while EPAPM25 has a negative effect on the occurrences, EPASO2 
has a positive effect. Also, we found some interesting patterns associated with the 
geographical variations of mortality rates and the relative occurrences of the four cancer 
types. 
Acknowledgments
Looking back on the time spent to accumulate the knowledge presented in this
dissertation, there have been many people who contributed directly or indirectly to
this work. To all of them, named or unnamed, I like to express my gratitude and
deepest appreciation.
First, I would like to express special thanks to my advisor Balgobin Nandram for
his endless help, guidance and patience, and for giving me the opportunity to do this
project.
I also wish to thank my two co-advisors Professor Hyunjoong Kim and Linda
Pickle (National Cancer Institute) for providing advice and assistance when necessary.
I would like to express my gratitude to the National Center for Health Statistics
and in particularly to the Oﬃce of Research and Methodology for giving me the
opportunity to work with them on this project during my summer internship.
In addition, I would like to extend a special thank to my family and friends
for all their support, particularly to my sister Elise, my brother-in-law Mohamed
and my special friend Maria who have been a constant source of love, reassurance,
encouragement and patience.
Thank you again to everyone involved.
iii
Contents
1 Introduction 2
1.1 Background . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
1.1.1 Source of Data . . . . . . . . . . . . . . . . . . . . . . . . . . 3
1.2 Preliminary Analyzes of the Observed Data . . . . . . . . . . . . . . 6
1.2.1 Methodology for Preliminary Analyzes . . . . . . . . . . . . . 6
1.2.2 Mapping the Observed Rates . . . . . . . . . . . . . . . . . . 8
1.3 Model for the λij . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21
1.4 Thesis Overview . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
2 Approximate Models 24
2.1 First Approximate Model for the pijk’s . . . . . . . . . . . . . . . . . 24
2.1.1 Model Description . . . . . . . . . . . . . . . . . . . . . . . . 24
2.1.2 Estimates and Maps . . . . . . . . . . . . . . . . . . . . . . . 26
2.1.3 Concluding Remarks . . . . . . . . . . . . . . . . . . . . . . . 35
2.2 Second Approximate Model for the pijk’s . . . . . . . . . . . . . . . . 35
2.2.1 Model Description . . . . . . . . . . . . . . . . . . . . . . . . 35
2.2.2 Estimates . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37
2.2.3 Maps . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45
2.3 Concluding Remarks . . . . . . . . . . . . . . . . . . . . . . . . . . . 50
iv
3 An Exact Model 51
3.1 Model for the λijk . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51
3.2 Assessing the Model Fit . . . . . . . . . . . . . . . . . . . . . . . . . 52
3.3 Estimates and Maps for the Death Rates . . . . . . . . . . . . . . . . 61
3.4 Analyses of Relative Occurences . . . . . . . . . . . . . . . . . . . . . 64
3.4.1 Model Description . . . . . . . . . . . . . . . . . . . . . . . . 64
3.4.2 Estimates and Maps . . . . . . . . . . . . . . . . . . . . . . . 65
3.5 Concluding Remarks . . . . . . . . . . . . . . . . . . . . . . . . . . . 83
4 Concluding Remarks 84
4.1 Review of Methodology . . . . . . . . . . . . . . . . . . . . . . . . . . 84
4.2 Final Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 85
4.3 An Alternative Approach . . . . . . . . . . . . . . . . . . . . . . . . . 86
Bibliography 89
Appendix 91
Appendix A : Model for the λij . . . . . . . . . . . . . . . . . . . . . . . . 91
Appendix B : First Approximate Model for the pijk . . . . . . . . . . . . . 94
v
List of Figures
1.1 Observed Death Rates for the four types of Cancer . . . . . . . . . . 13
1.2 Maps of the Observed Death Rates by Disease . . . . . . . . . . . . . 15
1.3 Maps of the Observed Death Rates by Disease . . . . . . . . . . . . . 16
1.4 Box Plots of the Observed Proportions of Deaths by types of Cancer 18
1.5 Maps of the Observed Proportions of Deaths (10−2) by Disease . . . . 19
1.6 Maps of the Observed Proportions of Deaths (10−2) by Disease . . . . 20
2.1 Box Plots of the Proportions of Deaths by Disease . . . . . . . . . . . 29
2.2 Maps of the Estimated Death Rates by Disease . . . . . . . . . . . . 31
2.3 Maps of the Estimated Death Rates by Disease . . . . . . . . . . . . 32
2.4 Maps of the Proportions of Deaths (10−2) by Disease . . . . . . . . . 33
2.5 Maps of the Proportions of Deaths (10−2) by Disease . . . . . . . . . 34
2.6 Box Plots of the Estimated Proportions of Death by Disease . . . . . 41
2.7 Box Plots of the Estimated Proportions of Deaths by Disease . . . . . 44
2.8 Maps of the Estimated Death Rates by Disease . . . . . . . . . . . . 46
2.9 Maps of the Estimated Death Rates by Disease . . . . . . . . . . . . 47
2.10 Maps of the Proportions of Deaths (10−2) by Disease . . . . . . . . . 48
2.11 Maps of the Proportions of Deaths (10−2) by Disease . . . . . . . . . 49
3.1 Plots of Residuals versus Standard Deviation of Residuals and Number
of Deaths . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 57
vi
3.2 Plots of Residuals versus Age and Region . . . . . . . . . . . . . . . . 57
3.3 Plots of Residuals and Standardized Residuals versus Predicted Rates 58
3.4 Box Plots of the Standarized Residuals versus Age Class . . . . . . . 59
3.5 Box Plots of the Standarized Residuals versus Region . . . . . . . . . 60
3.6 Box Plots of the Standarized Residuals versus Type of Cancer . . . . 60
3.7 Maps of the Estimated Death Rates by Disease . . . . . . . . . . . . 62
3.8 Maps of the Estimated Death Rates by Disease . . . . . . . . . . . . 63
3.9 Distribution of the Proportions of Death by Disease . . . . . . . . . . 66
3.10 Frequency Histogram for Epapm25 and Epaso2 . . . . . . . . . . . . 69
3.11 Frequency Histogram for φi . . . . . . . . . . . . . . . . . . . . . . . 69
3.12 Maps of the Proportions (10−2) of Death by disease for Age 40 . . . . 71
3.13 Maps of the Proportions (10−2) of Death by disease for Age 70 . . . . 72
3.14 Maps of the Proportions (10−2) of Death by disease for Age 85 and up 73
3.15 Maps of the Proportions (10−2) of Death for Prostate Cancer for High
and Low Epapm25 . . . . . . . . . . . . . . . . . . . . . . . . . . . . 75
3.16 Maps of the Proportions (10−2) of Death for Colon Cancer for High
and Low Epapm25 . . . . . . . . . . . . . . . . . . . . . . . . . . . . 76
3.17 Maps of the Proportions (10−2) of Death for Lung Cancer for High and
Low Epapm25 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 77
3.18 Maps of the Proportions (10−2) of Death for Other Cancer for High
and Low Epapm25 . . . . . . . . . . . . . . . . . . . . . . . . . . . . 78
3.19 Maps of the Proportions (10−2) of Death for Prostate Cancer for High
and Low Epapm25 . . . . . . . . . . . . . . . . . . . . . . . . . . . . 79
3.20 Maps of the Proportions (10−2) of Death for Colon Cancer for High
and Low Epapm25 . . . . . . . . . . . . . . . . . . . . . . . . . . . . 80
3.21 Maps of the Proportions (10−2) of Death for Lung Cancer for High and
Low Epapm25 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 81
vii
3.22 Maps of the Proportions (10−2) of Death for Other Cancer for High
and Low Epapm25 . . . . . . . . . . . . . . . . . . . . . . . . . . . . 82
viii
List of Tables
1.1 Number of HSAs with Zero Observed Deaths . . . . . . . . . . . . . . 8
1.2 Number of HSAs with Zero Observed Deaths After Combining the
First 4 Age Classes . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
1.3 Age Classes and Standard Population Used for Age Adjustment Taken
from Pickle et al. (1996) . . . . . . . . . . . . . . . . . . . . . . . . . 9
1.4 Number of HSAs by Region . . . . . . . . . . . . . . . . . . . . . . . 9
1.5 Mean and Standard Deviation per 100,000 population for the Observed
Death Rates (λijk) over HSAs . . . . . . . . . . . . . . . . . . . . . . 10
1.6 Median per 100,000 population for the Observed Death Rates (λijk)
over HSAs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
1.7 Mean (10−3) for the Observed pijk for Prostate Cancer by Region and
Age Class . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
1.8 Mean (10−3) for the Observed pijk for Colon Cancer by Region and
Age Class . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
1.9 Mean (10−3) for the Observed pijk for Lung Cancer by Region and Age
Class . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
1.10 Mean (10−3) for the Observed pijk for Other Cancer by Region and
Age Class . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
2.1 Mean and Standard Deviation per 100,000 population of the Death
Rates (λijk) over HSAs . . . . . . . . . . . . . . . . . . . . . . . . . . 27
ix
2.2 Mean and Standard Deviation of β over the 1000 Simulations . . . . 28
2.3 Mean and Standard Deviation of the Estimates of α . . . . . . . . . . 38
2.4 Mean and Standard Deviation of the Estimates of θjk . . . . . . . . . 38
2.5 Mean and Standard Deviation per 100,000 population of the Death
Rates (λijk) over HSAs . . . . . . . . . . . . . . . . . . . . . . . . . . 39
2.6 Mean and Standard Deviation of the Estimates of α . . . . . . . . . . 42
2.7 Mean and Standard Deviation of the Estimates of θjk . . . . . . . . . 42
2.8 Mean and Standard Deviation per 100,000 population of the Death
Rates (λijk) over HSAs . . . . . . . . . . . . . . . . . . . . . . . . . . 43
3.1 Posterior Predictive P-values by Region for Prostate and Colon Cancer 53
3.2 Posterior Predictive P-values by Region For Lung and Other Cancer . 54
3.3 Number of HSAs with Absolute Values of Residuals ≥3 and ≥4 by
Region . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 55
3.4 Number of HSAs with Absolute Values of Residuals ≥3 and ≥4 by Age
Class . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 55
3.5 Mean and Standard Deviation per 100,000 population of the Death
Rates (λijk) over HSAs . . . . . . . . . . . . . . . . . . . . . . . . . . 61
3.6 Mean, Standard Deviation and 95% Credible Interval for the Estimates
of the Parameters . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 67
1
Chapter 1
Introduction
1.1 Background
Mapping of mortality rates is a valuable public health tool. The primary objectives
in modeling mortality data for an atlas are to detect patterns in the mortality rates
and to identify outliers from these patterns (i.e., interesting “hot-spots”). Here, we
focus on cancer mortality analyses.
The 1996 Atlas (Pickle et al.) presents maps of 18 leading causes of death by sex,
age, and race in the United States for the period 1988-92. This is the ﬁrst publication
of maps of all leading causes of death in the United States on a small-area scale. In
this Atlas, information previously available only in tabular form or summarized on
single map is presented on multiple maps and graphs. Broad geographic patterns
by age class are highlighted by application of new smoothing algorithm, and the
geographic unit for mapping is deﬁned on the basis of patterns of health care. These
new features allow public health researchers to examine the data at several diﬀerent
levels, to discern clusters of similar rate areas, to visualize broad geographic patterns,
and to compare regional rate. With these additional tools, important geographic
patterns of cause-speciﬁc mortality can be more easily identiﬁed.
The age speciﬁc numbers of deaths were modeled for each combination of race,
sex, cause and place using mixed eﬀects generalized linear models. Brieﬂy, logarithm
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of the age speciﬁc rates were modeled as a function of age, allowing each HSA to have
a random slope within its particular region. Predicted age speciﬁc rates for each HSA
were smoothed using a weighted head banging algorithm, with weights equal to the
inverse of the rates of estimated standard errors.
Recently, there has been increased interest in inference about mortality rates for
small geographical areas. Nandram et al. (1999) compared alternative models for es-
timating age speciﬁc and age adjusted mortality rates for all cancer for white males.
They used Bayesian methods with four hierarchical models. The alternative speciﬁ-
cations diﬀer in their assumptions about the variation in log(λij) over health service
areas and age classes. See also Nandram et al. (1999a) for methods used on chronic
obstructive pulmonary disease. Gideon (1999) studied Bayesian methods on Poisson
regression models based on the ﬁrst model suggested by Nandram et al. (1999) for
breast cancer mortality data. Both non spatial and spatial analyzes were investigated,
by Gideon (1999).
1.1.1 Source of Data
The death counts and number at risk for this project were obtained from records
of all United States death certiﬁcates in the ﬁfty states and District of Columbia for
1988-92 and population data for 1990. The number of deaths by age, sex, place of
residence, and cause of death is based on original death certiﬁcates reported to the
National Center for Health Statistics (NCHS) by the States. Death certiﬁcates with
age not stated were excluded, 0.025 percent of the total. Race was classiﬁed following
standard procedures for United States statistics. Hispanics with no racial designation
are included in the “White” category.
The population counts from the 1990 census, classiﬁed by age, race, sex, and
county, were multiplied by ﬁve to create a denominator corresponding to the ﬁve
years of mortality data. In few instances where the calculated number of person
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years was less than the reported number of deaths, as when death occurred in a
sparsely populated county before census enumeration, the years at risk were inﬂated
to equal the total number of deaths due to any cause. The age classes are classiﬁed
as 0-4 years, 5-14 years, 15-24 years, . . . , 75-84 years, and 85 years and older, coded
as decades 0-.25, 1, 2, 3,. . . , 9 (Pickle at al., 1996). Further details on the method
of data collection may be found in the Technical Appendix of Vital Statistics of the
United States, 1990.
The quality of the data is determined by the accuracy and completeness of the
information from medical diagnosis to ﬁnal coding and processing of the underlying
cause of death. Beginning with mortality data for 1968, the underlying cause of death
has been determined by NCHS computerized system that consistently applies the
World Health Organization coding and selection rule to each death certiﬁcate using
all conditions reported by certiﬁer. Automation of these tasks and cross veriﬁcation
of medical conditions coding have reduced errors in assigning underlying cause of
death certiﬁcate information to less than one percent. However, the completeness
and accuracy of the information supplied on the certiﬁcate and the decedent’s medical
diagnosis remain a potential source of error.
Deaths were initially assigned to a county (or equivalent administrative unit, such
as independent city or parish) according to the residence of the deceased, regardless
of the place of death. There were in all 3141 geographical units, which were further
aggregated into Health Service Areas (Pickle et al., 1996) by a cluster analysis of
where residents aged 65 and over obtained routine short-term hospital care in 1988.
An HSA may be thought of as an area that is relatively self-contained with respect to
hospital care. The median number of counties per HSA is about 2 with range 1 to 20.
The median number of HSAs per state is 16 with range of 1 to 58. With exception
of New York City the area of each HSA is at least 250 square miles.
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This project examines the geographic eﬀects of regions as well as HSA. For this
project there are twelve regions and 798 HSA, three of the nine census divisions were
split to make a total of twelve regions to achieve greater homogeneity of rates (Pickle
et al. 1996).
We focus our analyzes on mortality data from all cancer for white males. Cancer
diseases are categorized as colon cancer, lung cancer, prostate cancer and a fourth
type which we call other cancer. This fourth type includes skin, esophagus, stomach,
liver, uterine cervix, multiple myeloma, lymphomas, leukemias, ovary, brain, testis,
mouth, pancreas, kidney, bladder, thyroid, larynx etc.
For each type of cancer we focus on, the death rates rise steadily with age. Lung
cancer has been the leading cause of cancer death in men since the 1950’s and prostate
cancer is primarily a disease of older men, with over 80 percent of all diagnoses
occurring over age 65.
For inference on the proportional distribution of cancer types, we used the covari-
ates income, poverty, education, and two other covariates.
The two other covariates are epapm25 and epaso2 and are called criteria pollu-
tants. The covariate epapm25 refers to dust, dirt, smoke and other particles sus-
pended in air. The national standard air quality includes up to 10 microns in diam-
eter. Epapm25 includes all the particulate matters up to 2.5 microns in diameter.
The particulate matters were identiﬁed as serious airbone threats to human health.
The covariate epaso2 accounts for sulphur dioxide (S02) which is closely tied to the
burning of coal with a high sulphur content. It can form acid rain and has indirect
health eﬀects through contamination of surface water. Sulphur dioxide levels and
particles matterns are higher in the Eastern United States.
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1.2 Preliminary Analyzes of the Observed Data
In this project we focus on all cancer data categorized as colon, lung, prostate and
other for white males. In this section, we perform preliminary analyzes on these data.
1.2.1 Methodology for Preliminary Analyzes
Let dijk and nij denote, respectively, the number of deaths and population at risk
(number of persons years) for age class j and disease k in HSA i (i = 1, . . . , 798; j =
1, . . . , 10, k = 1, . . . , 4). The age classes are 0− 4, 5 − 14, . . . , 75 − 84, 85 and up,
coded as 0.25, 1, . . . , 9, the midpoints of the decade intervals (decade 1 = .25, decade
j = j − 1, for j = 2, . . . , 10).
Our model assumes that the number of deaths, dijk
dijk|nij, λij, pijk
ind
∼ Poisson(nijλijpijk), (1.1)
where λij is the age speciﬁc mortality rate over all diseases, j = 1, . . . , 10 , k =
1, . . . , 4 ,
∑4
k=1 pijk = 1, i = 1, . . . , 798. Here pijk is the proportion of individuals at
age j who got cancer type k in HSA i.
All the models that we consider assume (1.1).
Inference is desired for
a) the age speciﬁc mortality rate λijk = λij pijk and,
b) the age adjusted rate Rik =
∑10
j=1 aj λij pijk where aj are weights proportional to
the U.S. population in 1940 (used in the atlas construction).
Let d, n, λ and p be the vector of the dijk, nij, λij and pijk respectively. The joint
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density of d is
f(d|n, λ, p) =
798∏
i=1
10∏
j=1
4∏
k=1
(nijλijpijk)dijke−nijλijpijk
dijk!
,
k∑
k=1
pijk = 1
=
798∏
i=1
10∏
j=1
{∏4
k=1(nijλijpijk)
dijke−nijλij∏4
k=1 dijk!
}
(1.2)
=
798∏
i=1
10∏
j=1
{
dij.!
∏4
k=1 p
dijk
ijk∏4
k=1 dijk!
}{
(nijλij)dij.e−nijλij
dij.!
}
(1.3)
=
{ 798∏
i=1
10∏
j=1
p(dij |pij, dij.)
} { 798∏
i=1
10∏
j=1
p(dij|λij)
}
.
We note that the likelihood function can be viewed is a product of a function of the
pijk and a function of the λij . Therefore, inference on the pijk and the λij can be
made separately. The ﬁrst is a Poisson likelihood and the second is a multinomial
likelihood.
By taking the log on both parts of equation (1.2), we get
log
(
f(d|n, λ, p)
)
∝
798∑
i=1
10∑
j=1
{ 4∑
k=1
dijk log (nijλijpijk)− nijλij
}
∝
798∑
i=1
10∑
j=1
4∑
k=1
dijk log (pijk) +
798∑
i=1
10∑
j=1
{
(
4∑
k=1
dijk) log (nijλij)− nijλij
}
.
It follows that the maximum likelihood estimator of λij is
λˆij =
dij.
nij
. (1.4)
and maximum likelihood estimator of pijk
pˆijk =
dijk
dij.
. (1.5)
Then, the maximum likelihood estimator of the age speciﬁc mortality rate λijk is
λˆijk = λˆij pˆijk, (1.6)
the age adjusted rate Ri is Rˆi =
∑10
j=1 aj λˆij pˆijk where aj are weights proportional
to the U.S. population in 1940 (used in the atlas construction).
We will call pˆijk, λˆij and Rˆi the observed values of pijk, λij and Ri respectivley.
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1.2.2 Mapping the Observed Rates
Table 1.1 contains the number HSA with zero observed deaths by age-class and dis-
ease. A very large Number of HSAs contains no observed death for age classes smaller
than 4. That is the data are very sparse.
Age Class Prostate Colon Lung Others
1 796 797 788 397
2 795 792 791 255
3 790 717 757 184
4 786 496 536 97
5 722 265 149 39
6 387 118 23 18
7 77 35 3 1
8 8 8 0 0
9 4 9 2 0
10 13 36 22 11
Table 1.1: Number of HSAs with Zero Observed Deaths
Age Class Prostate Colon Lung Others
1 776 469 520 47
2 722 265 149 39
3 387 118 23 18
4 77 35 3 1
5 8 8 0 0
6 4 9 2 0
7 13 36 22 11
Table 1.2: Number of HSAs with Zero Observed Deaths After Combining the First 4
Age Classes
Because of the sparseness of the data (Table 1.1), it is diﬃcult to map age classes
1, 2, 3 and 4. We combined the ﬁrst four age classes to form one so only 7 age classes
remain as shown in Tables 1.2 and 1.3. This table contains also the standard million
population used for age adjustment, proportional to total U.S. population in 1940.
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We can see in the table that there are still many HSAs with 0 observed deaths for
age class 1 and 2.
Age Class Age (years) Standard Population
1 0-34 594,159
2 35-44 139,237
3 45-54 117,811
4 55-64 80,294
5 65-74 48,426
6 75-84 17,303
7 85 and older 2,770
Table 1.3: Age Classes and Standard Population Used for Age Adjustment Taken
from Pickle et al. (1996)
Region 1 2 3 4 5 6 7 8 9 10 11 12
# HSA 23 49 38 88 88 121 45 105 115 40 38 48
Table 1.4: Number of HSAs by Region
Table 1.4 contains the number of HSAs per region. This is a table of 798 HSAs
over the continental U.S.
Since the data for the ﬁrst 4 age classes are too sparse across age class for prostate
and colon cancer, we deﬁned the death rate of the ﬁrst age class by the weighted
average {
λ∗i1 =
∑4
j=1 aj∗λij
∑4
j=1 aj
λ∗ij = λi(j+3) for j = 2, . . . , 7
Then, the age adjusted death rates were computed using the weights{
a∗1 =
∑4
j=1 aj
a∗j = a(j+3) for j = 2, . . . , 7.
In Tables 1.5 and 1.6 we present the mean, standard deviation and median of the
observed death rates over HSAs. The means for age class 1 are essentially zero and
9
they increase across age classes for each disease.
All Cancer Prostate Colon Lung
Age Class Mean Std Mean Std Mean Std Mean Std
1 6.6721 3.6171 0.0041 0.0400 0.2770 0.5738 0.2046 0.4737
2 36.487 15.335 0.1403 0.7101 3.5473 4.8244 7.7909 7.2059
3 154.52 43.986 2.3117 5.3532 14.689 12.313 59.662 27.873
4 504.25 99.938 22.969 14.994 46.763 22.326 216.91 71.176
5 1091.1 169.04 108.92 35.244 108.54 37.292 438.72 119.71
6 1855.6 249.46 331.19 90.699 211.30 73.614 577.32 154.11
7 2666.5 550.65 719.81 269.48 368.29 176.94 500.28 241.34
8 (Age adjusted) 160.02 20.645 15.138 2.9028 16.076 3.8540 58.272 14.948
Table 1.5: Mean and Standard Deviation per 100,000 population for the Observed
Death Rates (λijk) over HSAs
Age Class All Cancer Prostate Colon Lung
1 6.1852 0.0000 0.0000 0.0000
2 35.250 0.0000 2.7761 7.0054
3 153.98 1.0040 13.461 57.571
4 507.02 21.910 46.879 214.22
5 1104.8 107.45 105.76 433.53
6 1869.5 328.78 209.78 580.22
7 2663.7 709.44 359.00 487.41
8 (Age adjusted) 161.82 15.034 15.860 58.037
Table 1.6: Median per 100,000 population for the Observed Death Rates (λijk) over
HSAs
Tables 1.7, 1.8, 1.9 and 1.10 present the means of the observed proportions of
death pijk over HSAs by region and age class for each disease. The observed rates for
prostate cancer do not vary much among the regions while they increase across age
class except for region 1 and age class 1. This is due to the fact that there is little
spatial clustering for prostate cancer.
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Region 1 2 3 4 5 6 7
1 4.546 2.257 17.842 47.509 99.879 170.449 255.581
2 1.940 2.986 14.382 45.995 99.632 168.111 254.321
3 1.766 2.916 14.076 45.610 99.277 167.862 254.839
4 2.002 2.959 13.368 45.692 98.604 170.708 257.846
5 1.728 3.290 13.300 44.193 96.953 169.023 257.579
6 1.837 3.181 13.680 44.175 97.052 170.427 258.583
7 1.851 3.074 13.801 44.495 97.977 172.038 260.633
8 1.721 3.015 14.127 44.523 97.861 172.394 261.137
9 1.541 2.921 13.808 44.136 97.222 171.334 259.702
10 1.513 3.054 13.948 44.568 97.939 172.608 261.758
11 1.495 3.025 14.020 44.682 98.196 173.039 262.473
12 1.363 3.179 14.166 45.544 99.543 174.791 263.866
Table 1.7: Mean (10−3) for the Observed pijk for Prostate Cancer by Region and Age
Class
Region 1 2 3 4 5 6 7
1 38.182 82.957 91.359 102.574 122.905 134.179 151.832
2 39.525 81.723 93.953 110.361 125.177 137.503 153.308
3 40.228 83.671 95.420 107.217 120.841 133.336 149.101
4 41.035 85.538 92.407 101.107 113.425 125.835 143.655
5 42.083 88.517 90.295 97.402 109.149 123.200 142.247
6 40.402 88.743 93.055 98.829 109.744 123.815 145.022
7 40.222 89.095 93.345 99.249 109.783 123.719 144.790
8 40.038 88.328 93.767 99.185 109.541 123.685 144.661
9 39.928 88.575 92.922 97.531 106.780 121.312 142.594
10 39.392 88.950 92.687 97.735 106.465 120.621 141.924
11 39.185 88.883 92.742 97.764 106.336 120.595 141.761
12 37.754 87.482 91.651 97.192 105.828 119.485 139.642
Table 1.8: Mean (10−3) for the Observed pijk for Colon Cancer by Region and Age
Class
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Region 1 2 3 4 5 6 7
1 39.091 203.160 343.293 385.306 342.889 288.376 179.164
2 36.615 200.691 348.815 383.950 349.294 284.484 182.140
3 37.284 203.854 356.174 393.707 358.930 290.799 183.819
4 39.748 213.306 374.410 411.430 375.226 300.825 191.101
5 39.368 219.647 383.533 423.151 387.028 307.613 192.510
6 38.828 215.159 375.936 421.382 386.156 304.683 190.719
7 38.287 214.109 373.982 419.355 384.439 302.588 188.500
8 37.613 214.741 373.785 419.727 386.249 303.508 188.482
9 36.578 214.899 374.813 422.927 390.367 307.269 190.625
10 35.926 211.417 371.709 420.396 388.985 305.784 189.657
11 35.697 210.597 371.142 419.938 388.486 305.410 189.148
12 33.559 204.696 366.529 415.858 384.794 303.653 189.752
Table 1.9: Mean (10−3) for the Observed pijk for Lung Cancer by Region and Age
Class
Region 1 2 3 4 5 6 7
1 918.182 711.625 547.507 464.612 434.327 406.996 413.423
2 921.921 714.600 542.851 459.694 425.897 409.902 410.231
3 920.722 709.559 534.331 453.465 420.953 408.002 412.241
4 917.215 698.198 519.815 441.772 412.746 402.632 407.399
5 916.821 688.547 512.873 435.254 406.870 400.165 407.665
6 918.933 692.917 517.329 435.614 407.048 401.076 405.676
7 919.640 693.722 518.873 436.901 407.801 401.655 406.077
8 920.629 693.916 518.322 436.565 406.349 400.412 405.719
9 921.954 693.605 518.456 435.406 405.632 400.086 407.079
10 923.169 696.578 521.656 437.302 406.611 400.987 406.660
11 923.623 697.494 522.095 437.617 406.981 400.956 406.618
12 927.324 704.643 527.655 441.406 409.835 402.071 406.741
Table 1.10: Mean (10−3) for the Observed pijk for Other Cancer by Region and Age
Class
Figure 1.1 presents the age speciﬁc mortality rates for prostate, colon, lung and
other cancer. The death rates for prostate, colon and lung cancer are essentially zero
until age class 5 where they begin to increase steadily with age class. The observed
rates for lung cancer, which is the leading cause of cancer death in men, increase
quickly from age class 5 to 9 where it drops. Prostate cancer being primarily a dis-
12
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ease of older men with over 80 percent of all diagnoses occurring over age 65, is nearly 
zero until age class 5 an then increases steadily to be more frequent than lung cancer  
for age classes 9 an 10.  The death rates for colon cancer increase slowly compare to 
prostate and lung cancers after age class 4. 
 
Figure 1.1: Observed Death Rates for the four types of Cancer 
 
 
 
 
 
In Figures 1.2 and 1.3 we present the maps for the observed mortality rates. The
maximum likelihood estimates provide no smoothing. Apparently, there are no pat-
terns for prostate and colon cancer for age speciﬁc rates 40 and 70. However higher
adjusted rates are clustered in Mountain North and West North Central North for
prostate cancer, and in the North East (age 70) and East North Central for colon
cancer. For lung and all cancer, higher age speciﬁc and age adjusted mortality rates
are clustered around the Appalachian region (Mississippi to West Virginia).
Lung cancer has been the leading cause of cancer death among men since the
1950’s. Prostate cancer is primarily a disease of older men, with over 80 percent of
all diagnoses occurring over age 65.
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Fig. 1.2: Maps of the Observed Death Rates by Type of Cancer
73.926 - 119.293
66.729 - 73.926
60.44 - 66.729
54.978 - 60.44
50.178 - 54.978
43.053 - 50.178
9.415 - 43.053
11.37 - 95.694
8.292 - 11.37
5.865 - 8.292
1.983 - 5.865
0 - 1.983
533.92 - 892.857
465.344 - 533.92
409.556 - 465.344
343.175 - 409.556
63.694 - 343.175
Lung All Cancer
Age Adjusted
Age 40
Age 70
180.706 - 240.028
171.631 - 180.706
164.827 - 171.631
158.031 - 164.827
149.868 - 158.031
138.374 - 149.868
80.231 - 138.374
45.646 - 114.943
38.377 - 45.646
32.662 - 38.377
26.257 - 32.662
0 - 26.257
1216.264 - 2062.78
1137.808 - 1216.264
1068.17 - 1137.808
967.629 - 1068.17
310.078 - 967.629
Fig. 1.3: Maps of the Observed Death Rates by Type of Cancer
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Figure 1.4 contains the box plots of the observed proportions of death by disease
(pijk). For prostate cancer the proportion of death increase steadily with age classes
from around 0% to 26 %. Colon cancer seems to be low for all age classes, the pro-
portion of deaths increases slowly from 5% to 12%. The proportion of deaths for lung
cancer increases steadily until age 60 from 0% to 43% and then decreases to 19% at
age 85 and older. As expected, other cancer is the leading cause of death before age
30 with a proportion of about 95% and it is decreasing steadily across age class to
a proportion of about 42%. Lung cancer appears to be a disease of the middle age.
Other cancers aﬀect mostly young people.
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Figure 1.4: Box Plots of the Observe Proportions of Deaths by types of Cancer
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In Figures 1.5 and 1.6 we present the maps for the relative occurrences. The high
proportions of deaths by prostate cancer seem to be more frequent in the West side
of the country while they are clustered in the East North for colon cancer. For lung
cancer, higher proportions of deaths are clustered around the Appalachian region
(Mississippi to West Virginia).
1.3 Model for the λij
We use the fourth model suggested by Nandram et al. (1999) for the analysis of the
mortality rates from all cancer.
We assume that dij |nij, λij
ind
∼ Poisson(nijλij). We ﬁt a hierarchical model with
a single regression coeﬃcient. The basis model for the analysis is as follows
logλij = x
′
j β + νi + δj (1.7)
where x
′
j =
(
1, decadej, (decadej)2, (decadej)3,max{0, (decadej−knot)3}
)
with decade1 =
0.25 , decadej = j − 1 and for j = 2, . . . , 10.
It is assumed that νi|σ21
iid
∼ N
(
0, σ21
)
, δj|σ22
iid
∼ N
(
0, σ22
)
and the value of the knot
that maximizes the likelihood of U.S. marginal data is 6 for “all cancer”.
Here, p(β) = 1 and σ−21 , σ
−2
2 ∼ Γ(
a
2
, b
2
) where a = b = 0.002 to obtain a proper
diﬀuse prior.
Nandram et al. (1999) showed how to ﬁt this model for all cancer. They found
that the linear structure (1.7) provided a substantially improved ﬁt over a model in
which σ22 = 0. Note that logλij = x
′
j β will smooth the observed data too much.
Therefore, the smoothing is adjusted by adding two heterogeneous terms : νi and
δj. Note only the modest ten parameters δj are added. We describe the Metropolis-
Hastings algorithm in Appendix A.
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The computations were done by region. They ran 21000 iterates, “burning in”
1000 and choosing every 20th to obtain 1000 iterates which we used for output anal-
yses. We will call this model the NSP model.
1.4 Thesis Overview
In the current chapter, we started with descriptive and exploratory data analysis,
and we discussed the source of the data, data summary and pictorial representation
of the data using box plots and line plots. The maps of the observed age speciﬁc
and age adjusted death rates were also drawn. We observe that the data are very
sparse across age classes, especially for prostate and colon cancer. A problem of weak
identiﬁability across age class arose and was resolved by amalgamating the age classes.
In the present study we will perform Bayesian analyses of cancer mortality data
by type of cancer for white males. We focus on analyzing the relative occurrences of
each cancer type. Ultimately, we wish to determine patterns in the mortality data
and identify outliers from these patterns (i.e., interesting “hot-spots“). We investi-
gate Poisson regression model ﬁrst on 2 approximate models and then on an exact
one. We construct maps for both age speciﬁc and age adjusted mortality rates.
Since inference can be made separately on the mortality rates and the proportions
of death by type of cancer, two models have to be ﬁtted at a time. The model sug-
gested by Nandram, Sedransk and Pickle (1999) reviewed in Section 1.3, henceforth
the NSP model, is used to model the mortality rates (see Section 1.3). The objective
in this project remains to investigate models for the proportions of death by disease.
In Chapter 2, we will ﬁt two diﬀerent approximate models to the data. Maps will
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be constructed with the parameter estimates for age speciﬁc and age adjusted rates.
We also construct box plots for the proportions of deaths by cancer types.
In Chapter 3, we apply the model ﬁrst used to model the mortality rates by type
of cancer. This model is not much aﬀected by the sparseness of the data and we do
not need to amalgamate the age classes. We then deduce the proportions of death by
disease and ﬁt a more elaborate model which serves as an alternative and improved
model to the ﬁrst approximated one presented in Chapter 2. Maps for mortality rates
and proportions of death by type of cancer are obtained.
Finally, we present our conclusions, both methodological and substantive. We
also present an exact model that we would have preferred to ﬁt, but for which we
experienced much diﬃculty with the Markov Chain Monte Carlo implementation.
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Chapter 2
Approximate Models
In this chapter we describe and ﬁt two diﬀerent approximate models to the data be-
cause the data are very sparse (many HSAs have zero deaths) especially in the ﬁrst
4 age classes, we amalgamated them as follows: age classes 1,2,3,4 as group 1, 5 as
group 2, 6 as group 3, . . . , 10 as group 7.
No new model for the λij is discussed. We simply use the NSP model.
The two models for the pijk diﬀer in the eﬀects being included in this model. The
second approximate model serves as an alternative and improved model to the ﬁrst
one. This second model does not account for age class and disease distinctively, only
the interaction between age and disease remains. We also remove the intercept from
the covariates for computational stability.
2.1 First Approximate Model for the pijk’s
2.1.1 Model Description
First, we assume the multinomial logit
log
(
pijk
pij4
)
= Z
′
iα+ γj + ηk + δjk.
We use the corner point restrictions which are η3 = 0, γ1 = 0, δ1k = 0, for k = 1, 2, 3
(prostate, colon and lung respectively), k=4 corresponds to other cancer, δj3 =
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0, for j = 2, . . . , 7.
Then we take
log
(
pˆijk
pˆij4
)
= Z
′
iα+ γj + ηk + δjk + eijk, i = 1, . . . , 798, j = 1, . . . , 7, k = 1, 2, 3
(2.1)
where eij =
 eij1eij2
eij3
 ind∼ N(0, σ2wij
3∗3
)
and Zi is the matrix containing the 5 predictor
variables such as income, poverty, college, epapm25 and epaso2. The variable income,
epapm25 and epaso2 were divided by 10, 000 for computational stability. The pˆijk are
the MLEs with an adjustment for zeros.
In order to compute log
(
pijk
pij4
)
pijk=pˆijk
= log
(
dijk
dij4
)
, i = 1, 2, 3, we used the new
deﬁnition d∗ijk of dijk
d∗ijk =
{
10−6 if dijk = 0,
dijk otherwise.
Moreover, for small dijk, Pickle et al. (1996) have shown that one will obtain
better estimates of the λij and the pijk using more stable quantities obtained which
can be obtained computing the averages by regions for small dijk’s such as
d∗∗ijk =
{ ∑
i∈R
∑10
j=1 dijk∑
i∈R
∑10
j=1
∑
k dijk
∑
i∈R
∑
k dijk
nr
if dijk < 3,
dijk if dijk ≥ 3,
where R = region and nr = number of HSAs in the region R.
The last substitution is motivated by
∑
i∈R
∑10
j=1 dijk
∑
i∈R
∑10
j=1
∑
k dijk
≈ dijk∑
k dijk
and
∑
i∈R
∑
k dijk
nr
≈
∑
k dijk .
First we obtain the least square estimates of α, γ, η, δ. Let β ′ =
(
α′, γ′, η′, δ′
)
,
then we have
βˆ =
(
X
′
W−1X
)−1
X
′
W−1Y,
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Ĉov
(
βˆ
)
=
(
X
′
W−1X
)−1
σˆ2,
σˆ2 =
(
Y −Xβˆ
)′(
Y −Xβˆ
)/
(21× n− 26).
The following identity simpliﬁes the computations
X
′
W−1X =
n∑
i=1
X
′
iW
−1
i Xi and X
′
W−1Y =
n∑
i=1
X
′
iW
−1
i Yi .
Then we approximate the distribution of these parameters by a normal distribu-
tion
βˆ ∼ N26
(
β,
̂
Cov
(
βˆ
))
.
Now pretending as though β has a uniform non informative prior, we have
β|data ∼ N26
(
β,
̂
Cov
(
βˆ
))
. (2.2)
It is straight forward to obtain a sample of 1000 random deviates from (2.2). By
substituting these into (2.1) we obtain an approximation to the distribution of {pijk},
see Appendix A. However, this is a rough way to smooth the MLEs of the pijk.
2.1.2 Estimates and Maps
In order to draw the maps, 1000 of pijk and λij were drawn from the starts ob-
tained from the previous models as explained in the previous sections. One sample
of 1000 death rates λijk = λij pijk and adjusted death rates Rik =
∑10
j=1 aj λij pijk
were deduced. We summarize the results by maps using only the means and standard
deviations of the sample. Each age class and disease were considered separately for
mapping across the U.S.
In Table 2.1 we present E(.|d) and SD(.|d) for the age speciﬁc and age adjusted (age
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All Cancer Prostate Colon Lung
Age Class Mean Std Mean Std Mean Std Mean Std
1 6.083 1.162 .0000 .0000 .5561 .1088 .2023 .0401
2 37.45 5.104 .0002 .0000 5.848 .8455 8.325 1.222
3 152.9 20.65 3.941 .5549 21.93 3.093 55.88 7.981
4 512.5 62.14 28.74 3.600 120.6 14.90 183.6 23.34
5 1070 149.7 115.8 16.66 241.2 34.34 358.5 52.37
6 1887 188.1 324.5 32.82 430.4 43.24 507.1 52.15
7 2724 263.6 657.3 63.80 650.6 62.94 480.1 47.33
8 160.0 17.46 15.82 1.656 34.34 3.806 50.06 5.916
Table 2.1: Mean and Standard Deviation per 100,000 population of the Death Rates
(λijk) over HSAs
class 8) rates averaged over HSAs. They look similar to the observed rates except
for colon cancer for which the estimated rates are almost two times larger than the
observed ones after age class 2, and for prostate cancer for which the rates are overes-
timated until age class 5. Based on the model, the estimated age mortality rates for
age class 1 are still approximately zero. We observe that the values of the estimates
increase across age class.
Table 2.2 presents the means over the 1000 simulations of the parameter estimates.
The estimates follow the patterns observed in the mortality data. The estimates
accounting for prostate and colon cancer are mostly negative except for prostate
cancer at age class 7 (85 and older) since lung cancer is the leading cause of cancer
death and the disease for which the ﬁxed eﬀect on disease η3 = 0. The parameter
estimates accounting for age class and disease are signiﬁcant. The proportion of
deaths by prostate cancer increases. For colon cancer, they increase until age class
4 (age 60) and then drop. For lung cancer, they increase with age class and drop
after age class 7 (85 and older) as in the observed data. Concerning the covariates,
we observe that the most signiﬁcant are the intercept, epapm25 and income. The 4
remaining covariates do not seem to explain a lot of the variation. We also can notice
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Covariates Mean Std Ratio
Intercept -3.049 0.2361 -12.9
% Income -.1377 0.0291 -4.73
% Poverty -.0082 0.0042 -1.95
% College -.0027 0.0031 -0.87
Epapm25 -6.623 1.4569 -4.55
Epaso2 0.9549 0.3745 2.55
γ2 2.2881 0.2363 9.68
γ3 3.0728 0.2308 13.31
γ4 3.3400 0.2284 14.58
γ5 3.3273 0.2289 14.53
γ6 3.1083 0.2295 13.53
γ7 2.6501 0.2300 11.52
δ21 -1.595 1.5512 -1.03
δ31 6.9297 1.2255 5.65
δ41 8.1146 1.2167 6.67
δ51 8.9451 1.2141 7.37
δ61 9.7457 1.2119 8.04
δ71 10.639 1.2114 8.78
δ22 -1.139 1.0393 -1.10
δ32 -1.700 1.0369 -1.64
δ42 -1.786 1.8730 -0.95
δ52 -1.588 1.5987 -0.99
δ62 -1.234 1.5911 -0.77
δ72 -.6002 1.5928 -0.38
η1 -10.27 1.9714 -5.21
η2 0.3418 1.5950 .21
Table 2.2: Mean and Standard Deviation of β over the 1000 Simulations
that the parameters corresponding to the age classes are all signiﬁcant. However the
interaction of age class and disease is only signiﬁcant for prostate cancer and after
age class 1. The parameter accounting for disease is very signiﬁcant for prostate but
is not for colon cancer.
In Figure 2.1 we present the distributions of the proportions of deaths by disease. The
box plots are similar to the one obtained from the observed proportions in Figure 1.4
for prostate, lung and other cancers. However the pattern for colon cancer is quite
similar across age class but the proportions are overestimated.
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Figure 2.1: Box Plots of the Proportions of Deaths by Disease
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In Figure 2.2, 2.3, 2.4 and 2.5 we present the maps of the mortality rates (for age
speciﬁc 40, 70 and age adjusted) and of the relative occurrences respectively. The
same pattern is observed for each disease and each age class as a concentration of
high mortality rates around the Appalachian region (Mississippi to West Virginia).
We observe that the mortality rates obtained for colon cancer are slightly diﬀerent
from the observed ones as in Table 2.1.
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Fig. 2.2: Maps of the Estimated Death Rates by Type of Cancer
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Fig. 2.3: Maps of the Estimated Death Rates by Type of Cancer
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Fig 2.4: Maps of the Proportions of Deaths (10-2)
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Fig 2.5: Maps of the Proportions of Deaths (10-2)
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2.1.3 Concluding Remarks
We ﬁtted a simple approximate model to the pijk that does not account for hetero-
geneity among health service areas. As expected, this approximate model does not
appear to ﬁt the data very well. Our mapping suggests that the proportion of death
follow the same pattern across age classes and speciﬁc types of cancer, of course, with
diﬀerent intensities which give us the same pattern for the all cancer map and the
speciﬁc disease maps.
The objective in the next section is to provide distinct patterns for each disease
across age classes. To do so we investigate the ﬁt of another approximate model which
will serve as an alternative and improved model to the previous one by obtaining
slightly smoother estimates and maps with age and disease speciﬁc patterns.
2.2 Second Approximate Model for the pijk’s
2.2.1 Model Description
We only modify the model for the pijk’s and use the same model for the λij as the
one we proposed in Section 2.1. We retain the 7 age classes.
We looked at the multinomial logit ﬁxed eﬀects model
yijk = log
(
pijk
pij4
)
= Z
′
iα + θjk + eijk,
where i = 1, . . . , N, j = 1, . . . , c, k = 1, 2, 3, and eij
ind
∼ N
(
0, σ2jwij
3∗3
)
.
Z
′
i is deﬁned as in Section 2.2 but without an intercept, σ
−2
j ∼ Γ(
a
2
, b
2
) , a = b =
0.002 for j = 1, . . . , c, and there are no constraints on the θjk.
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Then y
ij
ind
∼ N
(
Z
′
iα+ θj , σ
2
jW
−1
ij
)
.
Letting N = 798, c = 7 and W−1ij = Ωij, the joint posterior density obtained by
assuming ﬂat priors for all location parameters is
p(α, θj , σ
2
j |d) ∝
N∏
i=1
c∏
j=1
{(
1
σ2j
)3/2
e
− 1
2σ2
j
(y
ij
−(Z
′
iα+θj ))
′
W−1ij (yij−(Z
′
iα+θj ))
}
×
c∏
j=1
(
1
σ2j
)a/2+1
e
− b
2σ2j .
Then we can deduce the posterior distribution
σ−2j |α, θj , d ∼ Γ
(
3N + a
2
,
b+
∑
i(yij − (Z
′
iα+ θj))
′
Ωij (yij − (Z
′
iα+ θj))
2
)
.
(2.3)
Since the conditional posterior densities of α and θj are diﬃcult to identify, we use
the second order Taylor’s series approximation. We ∆ denote the logarithm of the
conditional posterior density for each parameter such as for example for α
∆(α) ∝
∑
i,j
1
σ2j
3∑
k1,k2=1
(yijk1 − (Z
′
iα+ θjk1)) Ωijk1k2 (yijk2 − (Z
′
iα+ θjk2))
Then
d∆(α)
dα
= −
∑
i,j
1
σ2j
3∑
k1,k2=1
Ωijk1k2 (yijk2 − (Z
′
iα+ θjk2))Zi
d2∆(α)
dα2
=
∑
i,j
1
σ2j
3∑
k1,k2=1
Ωijk1k2 Zi Z
′
i
Therefore, we approximate the distribution of α by
α|θj, σ
−2
j
ind
∼ N
{(∑
i,j
1
σ2j
3∑
k1,k2=1
Ωijk1k2 Zi Z
′
i
)−1
(∑
i,j
1
σ2j
3∑
k1,k2=1
Ωijk1k2 (yijk2 − θjk2)Zi
)
,
(∑
i,j
1
σ2j
3∑
k1,k2=1
Ωijk1k2 Zi Z
′
i
)−1}
.(2.4)
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By the same methodology, we approximate the distribution of θj by
θj|α, σ
−2
j
ind
∼ N
{(∑
i
Ωij
)−1 (∑
i
Ωij (yij − Z
′
iα)
)
, σ2j
(∑
i
Ωij
)−1}
(2.5)
We use the Gibbs sampler to generate 1000 estimates of α, θ drawing from (2.3),
(2.4) and (2.5) in turn; the convergence was rapid. In fact, we dropped out the ﬁrst
100 and took the next 1000 iterates to make inference.
Finally, we deduce the corresponding 1000 pijk as explained in Appendix B from
the Gibbs estimates so we have an estimate of the distribution of the pijk each based
on 1000 samples. The idea is to have smooth estimates of the pijk. This is a slightly
reﬁned procedure relative to the ﬁrst one presented in the previous section.
We could have separated out θjk into its components as in the ﬁrst approximation
but we simplify the computations somewhat.
2.2.2 Estimates
We look at two cases. In the ﬁrst case the reference parameter is other cancer and
the second case the reference parameter is prostate cancer.
Reference Parameter is Other Cancer
Tables 2.3 and 2.4 present the means over the 1000 simulations of the parameter
estimates. The estimates follow the patterns of the observed mortality data. All the
parameters are signiﬁcant except poverty.
In Table 2.5 we present E(.|d) and SD(.|d) for the age speciﬁc and age adjusted
(age class 8) rates average over HSAs. They look similar to the observed ones except
for colon cancer for which the estimated rates are underestimated after age class 2 and
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Covariates Estimates
Mean Std Interval Ratio
% Income -0.112 0.018 [-0.124, -0.100] -6.22
% College -0.007 0.003 [-0.009, -0.006] -2.33
% Poverty -0.004 0.0027 [-0.006, -0.003] -1.48
Epapm25 -4.709 0.988 [-5.387 ,-4.034] -4.77
EpaSO2 0.7217 0.251 [0.553, 0.883] 2.87
Table 2.3: Mean and Standard Deviation of the Estimates of α
Prostate Colon Lung
Age Class Mean Std Mean Std Mean Std
1 -13.713 0.350 -2.780 0.081 -3.087 0.078
2 -15.624 0.325 -1.761 0.047 -0.740 0.038
3 -4.721 0.107 -1.857 0.046 0.127 0.037
4 -2.894 0.047 -1.749 0.042 0.478 0.035
5 -1.636 0.038 -1.529 0.040 0.499 0.035
6 -0.659 0.035 -1.250 0.036 0.220 0.034
7 0.037 0.035 -0.948 0.039 -0.484 0.037
Table 2.4: Mean and Standard Deviation of the Estimates of θjk
for prostate cancer for which the estimated rates are underestimated until age class 6.
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All Cancer Prostate Colon Lung
Age Class Mean Std Mean Std Mean Std Mean Std
1 6.078 1.160 .0000 .0000 .2745 .0534 .2020 .0393
2 37.51 5.198 .0000 .0000 3.367 .4914 9.342 1.364
3 152.8 20.69 .5323 .0748 9.292 1.305 67.56 9.488
4 512.3 62.19 9.123 1.141 28.65 3.582 265.6 33.21
5 1069 149.2 62.64 8.991 69.68 10.00 529.6 76.01
6 1887 187.6 294.1 29.68 162.9 16.44 708.2 71.48
7 2723 260.6 853.5 82.02 318.7 30.63 506.7 48.69
8 159.9 17.42 11.28 1.105 11.10 1.215 70.01 8.103
Table 2.5: Mean and Standard Deviation per 100,000 population of the Death Rates
(λijk) over HSAs
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In Figure 2.6 we present the distribution of the proportions of death (pijk) by
disease. The patterns of the box plots across the age classes look similar to the one
obtained from the observed proportions in Figure 1.4 for prostate, lung and other
cancers but smoothed. The patterns across age classes and the estimated proportions
are similar.
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Figure 2.6: Box Plots of the Estimated Proportions of Death by Disease
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Reference Parameter is Prostate Cancer
Tables 2.6 and 2.7 present the means over the 1000 simulations of the parameter
estimates. The estimates follow the patterns of the observed mortality data. All the
parameters are signiﬁcant except epapm25.
Covariates Estimates
Mean Std Interval Ratio
% Income 0.232 0.039 [.206,.258] 5.95
% College -0.037 0.006 [-.041,-.033] -6.17
% Poverty 0.008 0.004 [.005,.011] 2
Epapm25 2.987 2.098 [1.59,4.39] 1.42
EpaSO2 1.188 0.538 [.829,1.55] 2.21
Table 2.6: Mean and Standard Deviation of the Estimates of α
Prostate Colon Lung
Age Class Mean Std Mean Std Mean Std
1 8.938 0.160 10.392 1.393 17.511 1.364
2 9.431 0.190 12.234 0.676 15.569 0.411
3 2.253 0.177 5.218 0.443 6.514 0.213
4 -0.186 0.088 2.637 0.146 2.886 0.091
5 -0.842 0.073 1.588 0.086 1.760 0.075
6 -1.110 0.073 0.591 0.079 1.128 0.074
7 -1.173 0.074 -0.597 0.088 0.774 0.082
Table 2.7: Mean and Standard Deviation of the Estimates of θjk
In Table 2.8 we present E(.|d) and SD(.|d) for the age speciﬁc and age adjusted
(age class 8) rates average over HSAs. They look similar to the observed rates except
for colon and prostate cancer for which the estimated rates are underestimated.
In Figure 2.7 we present the distribution of the proportions of deaths by disease.
The patterns of the box plots across age classes and the estimated proportions of death
little bit diﬀerent from the one obtained from the observed proportions in Figure 1.4
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All Cancer Prostate Colon Lung
Age Class Mean Std Mean Std Mean Std Mean Std
1 6.078 1.160 .0000 .0000 .0029 .0006 .0345 .0066
2 37.51 5.198 .0000 .0000 .0858 .0119 1.686 .2336
3 152.8 20.69 .1399 .0183 1.708 .2314 34.04 4.610
4 512.3 62.19 12.20 1.421 12.71 1.547 213.7 26.02
5 1069 149.2 71.54 9.612 38.59 5.422 438.5 61.62
6 1887 187.6 250.1 23.95 103.2 10.49 565.7 57.49
7 2723 260.6 568.2 54.19 220.2 21.71 391.9 38.63
8 159.9 17.42 10.36 .9589 5.500 .5681 53.54 6.003
Table 2.8: Mean and Standard Deviation per 100,000 population of the Death Rates
(λijk) over HSAs
for prostate, lung and other cancers. Indeed the proportions of death for prostate
and colon cancer are underestimated.
The box plots obtained with other cancer as the reference match the observed
ones better.
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Figure 2.7: Box Plots of the Estimated Proportions of Deaths by Disease
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2.2.3 Maps
Since the results are similar but match the observed mortality rates better with other
cancer as the reference parameter, we only drew and analyzed the corresponding maps.
In Figures 2.8 and 2.9 we present the maps for age speciﬁc (40, 70) and age ad-
justed mortality rates by disease. The same pattern of concentration of high mortality
rates around the Appalachian region (Mississippi to West Virginia) is observed for
each age class across disease. Only a slight improvement is observed compared to the
ﬁrst approximate model ﬁtted in Section 2.2.
In Figures 2.10 and 2.11 we present the maps for age speciﬁc 40 and 70 of the
proportions of deaths by type of cancer. The map for prostate cancer at age 40
clearly show that the model encounters major diﬃculties. The remaining maps show
some improvement from the ﬁrst model since they match the maps of the observed
proportions presented in chapter 1 better.
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Figure 2.8: Maps of the Estimated Death Rates by Disease
46
78.775 - 100.841
74.693 - 78.775
72.079 - 74.693
69.031 - 72.079
65.642 - 69.031
60.773 - 65.642
41.064 - 60.773
10.582 - 13.72
9.712 - 10.582
9.044 - 9.712
8.218 - 9.044
5.105 - 8.218
589.968 - 775.667
556.354 - 589.968
526.43 - 556.354
477.001 - 526.43
284.172 - 477.001
177.557 - 227.122
170.596 - 177.557
164.723 - 170.596
159.349 - 164.723
151.279 - 159.349
139.632 - 151.279
95.829 - 139.632
42.052 - 53.091
39.115 - 42.052
36.535 - 39.115
33.802 - 36.535
20.901 - 33.802
1187.173 - 1548.201
1124.228 - 1187.173
1066.463 - 1124.228
959.745 - 1066.463
591.174 - 959.745
Lung All Cancer
Age 40
Age 70
Age Adjusted
Fig. 2.9: Maps of the Estimated Death Rates by Type of Cancer
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Fig 2.10: Maps of the Proportions of Deaths (10-2)
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Fig 2.11: Maps of the Proportions of Deaths (10-2)
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2.3 Concluding Remarks
In this section we introduced two simple approximate models for the pijk that seem
to account well for heterogeneity among Health Service Areas for each disease. The
maps have the same pattern for each disease.
Only slight improvements were observed with the second model. The estimates
are still very smoothed and our mapping still suggests that the proportions for each
disease category do not change among HSA. Besides the distribution of the propor-
tions of death by disease obtained from the second approximation are closer to the
observed ones.
Since the data are very sparse for prostate cancer, we ﬁtted the model twice, once
with reference parameter others cancer and once with prostate cancer. The results
are slightly closer to the observed data with other cancer as the reference.
In Chapter 3, we follow up further by ﬁrst ﬁtting the model used previously
for the λij to the λijk and then ﬁt an improve model to the pijk.
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Chapter 3
An Exact Model
The objective in this chapter is to investigate if there are diﬀerent map patterns for
each type of disease, and to obtain improved precision.
The models we studied in the previous chapters did not ﬁt the data well because
they produce one map pattern among the diﬀerent types of cancer. In this chapter,
we ﬁrst focus on a model for the λijk which is a generalization of the model presented
in Chapter 2 for the λij to each disease, and then we deduce the proportions of death
by disease pijk.
Note, in particularly, in this chapter we use all 10 age classes.
3.1 Model for the λijk
The basis model generalized from (1.7) is as follows
logλijk = x
′
j βk + νik + δjk
where x
′
j =
(
1, decadej, (decadej)2, (decadej)3,max{0, (decadej−knot)3}
)
with decade1 =
0.25 , decadej = j − 1 for j = 2, . . . , 10 and k = 1, . . . , 4 for each disease prostate,
colon, lung and others cancer respectively.
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It is assumed that νik|σ21k
iid
∼ N
(
0, σ21k
)
, δjk|σ22k
iid
∼ N
(
0, σ22k
)
, and the value of the
knot that maximizes the likelihood of U.S. marginal data is 6 for “all cancer”.
Here, p(β) = 1 and σ−21k , σ
−2
2k ∼ Γ(
a
2
, b
2
) where a = b = 0.002 to obtain a proper
diﬀuse prior.
The Metropolis-Hastings algorithm was used based in a manner similar to that in
Appendix A but applied to each disease.
By trial and error, we chose the tuning constants between 6 and 10 (see Appendix
A).
The computations were done by region. We ran 11, 000 iterates, “burning in” 1000
and choosing every tenth to obtain 1000 iterates which we used for output analyzes.
3.2 Assessing the Model Fit
We have used two diﬀerent measures to assess the model.
The ﬁrst measure that we used to assess the model is the posterior predictive
p-value; i.e.,
Pr{T (dnew, λ) ≥ T ((dobs, λ) | dobs}. (3.1)
Very small or very large values of (3.1) are sometimes used to discredit a model
(Gelman et al. 1995, Chapter 6). A model is considered acceptable if the p-value is
between 0.05 and 0.95. We have used three checking functions, T (dnew, λ), analogous
to the three discrepancy measures, P (dobs, dnew):
1. Chi-square ∑
i
∑
j
(dijk − nijλijk)
2/nijλijk.
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2. Rank-based
√
12
∑
i
∑
j
{cijk/(a+ 1) − 0.5}(dijk − nijλijk)
where a = 10 and cijk = rank(dijk − nijλijk).
3. Poisson-based
2
∑
i
∑
j
{
(dijk + 0.5) ln
(
dijk + 0.5
nijλijk + 0.5
)
− (dijk − nijλijk)
}
.
Region Prostate Colon
Chi-Square Poisson-based Rank-based Chi-Square Poisson-based Rank-based
1 0.157 0.185 0.125 0.418 0.116 0.126
2 0.920 0.642 0.237 0.519 0.149 0.055
3 0.935 0.745 0.406 0.271 0.000 0.001
4 0.222 0.051 0.060 0.458 0.005 0.072
5 0.928 0.540 0.418 0.884 0.318 0.328
6 0.791 0.532 0.283 0.305 0.000 0.005
7 0.729 0.099 0.036 0.220 0.282 0.461
8 0.923 0.721 0.637 0.615 0.876 0.568
9 0.348 0.227 0.188 0.305 0.002 0.022
10 0.426 0.117 0.165 0.373 0.372 0.388
11 0.948 0.454 0.393 0.275 0.676 0.779
12 0.874 0.395 0.103 0.187 0.002 0.001
Table 3.1: Posterior Predictive P-values by Region for Prostate and Colon Cancer
In Table 3.1 and 3.2 we present the p-values of the three checking functions of the
model by region for each disease. Most of the chi-square p-values lie between 0.05 and
0.95 across region for prostate and colon cancer but not for lung and other cancer.
The ﬁt for lung cancer seems unreasonable based on this measure. These p-values
are very sensitive to outliers and an extreme outlier could force them to zero.
The second method of evaluating the model is to use a cross-validation. Let d(ijk)
denote the set of all d’s except for (ijk). Then deﬁne the cross-validation residual as
aijk = rijk − E(rijk | d(ijk)), and the standardized cross-validation residual as
DRESijk =
rijk − E(rijk | d(ijk))
SD(rijk | d(ijk))
. (3.2)
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Region Lung Others
Chi-Square Poisson-based Rank-based Chi-Square Poisson-based Rank-based
1 0.120 0.044 0.018 0.575 0.628 0.303
2 0.238 0.000 0.002 0.000 0.000 0.000
3 0.083 0.000 0.004 0.000 0.000 0.020
4 0.004 0.000 0.000 0.000 0.000 0.000
5 0.134 0.000 0.000 0.194 0.061 0.121
6 0.008 0.000 0.000 0.428 0.515 0.611
7 0.312 0.255 0.019 0.009 0.024 0.205
8 0.103 0.000 0.000 0.011 0.045 0.009
9 0.097 0.000 0.000 0.068 0.037 0.029
10 0.062 0.000 0.000 0.093 0.066 0.030
11 0.258 0.024 0.058 0.194 0.356 0.285
12 0.218 0.022 0.008 0.002 0.000 0.046
Table 3.2: Posterior Predictive P-values by Region For Lung and Other Cancer
That is, the (ijk)-th observed rijk is “held out” and compared with its point estima-
tor, E(rijk | d(ijk)), which is evaluated without using the observed dijk. We employ the
cross-validation residuals and standardized residuals as absolute measures of the con-
cordance of the data with a proposed model. To summarize we count (a) the number
of (ijk) such that | DRESijk |≥ q which we call “# outliers” and (b) the number of
HSAs such that | DRESijk |≥ q for at least one j, which we call “# HSAs”. In Table
3.3 we present the number of HSAs with outliers ≥ 3 and 4 by region. (Table 1.4
contains the number of HSAs per region). As can be seen regions 4 and 9 have the
most number of HSAs with residuals greater than 3 and 4. It indicates that regions
4 and 9 are not ﬁtted well. Table 3.4 contains the number of HSAs with outliers ≥ 3
and 4 by age class. The model does not seem to ﬁt the data very well at the age
classes 5 and 9 for prostate cancer, 3 to 5 for colon cancer, all the age classes for lung
cancer and all the age classes but the last one for other cancer.
The large number of HSAs with outliers comes from the fact that the data are
very sparse across age class.
Finally we decide to assess the model by looking at the residual plots for all dis-
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Region Prostate Colon Lung Others
#HSA≥3 #HSA≥4 #HSA≥3 #HSA≥4 #HSA≥3 #HSA≥4 #HSA≥3 #HSA≥4
1 1 1 5 2 17 0 2 0
2 4 2 5 1 11 5 7 5
3 3 1 8 2 18 2 10 2
4 38 20 10 2 28 2 11 2
5 5 3 8 1 14 0 5 0
6 12 6 19 4 44 1 7 1
7 2 1 6 2 4 3 10 3
8 5 4 13 5 21 7 13 7
9 10 6 21 8 43 3 13 3
10 5 2 5 3 24 1 4 1
11 0 0 8 3 4 3 7 3
12 4 0 12 7 8 2 8 2
Table 3.3: Number of HSAs with Absolute Values of Residuals ≥3 and ≥4 by Region
Age Prostate Colon Lung Others
#HSA≥3 #HSA≥4 #HSA≥3 #HSA≥4 #HSA≥3 #HSA≥4 #HSA≥3 #HSA≥4
1 0 0 0 0 8 7 17 8
2 1 1 3 1 6 5 13 3
3 7 5 20 8 18 13 13 3
4 3 3 32 11 17 7 9 3
5 24 16 20 4 12 6 8 3
6 9 6 12 1 34 5 14 4
7 8 2 8 3 42 19 8 1
8 9 2 8 5 67 36 5 1
9 23 10 10 5 27 10 9 3
10 5 1 7 2 10 4 1 0
Table 3.4: Number of HSAs with Absolute Values of Residuals ≥3 and ≥4 by Age
Class
eases simultaneously.
In Figures 3.1 we present the plot of residual against standard deviation of resid-
ual, SD(rijk|dijk) and the plot of aijk versus number of death. We provide bands of
|rijk − E(rijk|d(ijk))| ≤ 2 SD(rijk|dijk) which in fact gives it a funnel shape, where
both sides of the funnel have some outliers. The other plot is residual aijk against
number of death dijk. This is indicating that the model provides a good ﬁt.
Figures 3.2 are the plots of residual aijk against age and region. The plot against
age shows the increase in variation as the age increases, the highest being age class
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10, i.e. 85 years and above. There is symmetry about zero as can be seen from the
two types of plots, against age and region. These are further good indications of the
ﬁt of the model.
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Figure 3.1: Plots of Residuals versus Standard Deviation of Residuals and Number of 
Deaths 
 
 
Figure 3.2: Plots of Residuals versus Age and Region 
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Figure 3.3 shows the plots of residual aijk and standardized residuals against the 
predictive rates, λijk for the 4 diseases simultaneously.  In a Normal distribution model, 
these plots should be a null plot, i.e. no pattern, but in our case it is a Poisson distribution 
model.  The mean of the Poisson is directly proportional to the variance, hence the 
megaphone shape is expected.  The interesting characteristic is its symmetry about zero. 
 
 
Figure 3.3: Plots of Residuals and Standardized Residuals versus Predicted Rates 
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The box plots of the standardized residuals versus age class, region and type of 
cancer presented in Figures 3.4, 3.5, and 3.6 do not show any departure from the 
symmetrical pattern about zero. 
 
 
Figure 3.4: Box Plots of the Standardized Residuals versus Age Class 
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Figure 3.5: Box Plots of the Standardized Residuals versus Region 
 
Figure 3.6: Box Plots of the Standardized Residuals versus Type of Cancer 
3.3 Estimates and Maps for the Death Rates
Table 3.5 presents the mean and standard Deviation of the death rates, λijk, over
HSAs. The death rates increase with age class for each disease. They are very similar
to the observed ones presented in Table 1.5.
All Cancer Prostate Colon Lung
Age Class Mean Std Mean Std Mean Std Mean Std
1 3.686 .4384 .0548 .0655 .0297 .0300 .0097 .0164
2 3.551 .4011 .0121 .0071 .0345 .0171 .0117 .0119
3 5.584 .6812 .0114 .0058 .1127 .0413 .0609 .0291
4 11.68 1.375 .0262 .0202 .6111 .1648 .6845 .1791
5 36.20 5.016 .1576 .0694 3.140 .5620 7.519 1.876
6 151.7 21.71 2.263 .4328 13.94 1.662 55.86 13.02
7 509.6 64.12 22.68 3.269 47.51 5.335 213.8 42.93
8 1090 124.1 107.6 15.99 108.9 14.74 427.6 76.03
9 1870 188.1 326.8 47.80 214.1 27.43 572.9 86.58
10 2711 255.1 714.8 107.7 365.1 42.67 510.7 74.37
11 160.3 18.13 14.97 2.184 16.01 1.874 56.95 10.50
Table 3.5: Mean and Standard Deviation per 100,000 population of the Death Rates
(λijk) over HSAs
In Figure 3.7 and 3.8 we present the maps for age speciﬁc 40, 70 and age adjusted
mortality rates by disease. Since the data are very sparse for age younger than 40
years for prostate and colon cancers, the corresponding maps have to be interpreted
with caution. The maps show interesting hot spots for prostate cancer in the North
West and North Central regions. For colon cancer, the high mortality rates are con-
centrated in the regions of the North East and east North Central. The high mortality
rates for lung cancer and all cancers are both concentrated in the South East region
for each age class.
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Fig. 3.7: Maps of the Estimated Death Rates by Type of Cancer
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Fig. 3.8: Maps of the Estimated Death Rates by Type of Cancer
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3.4 Analyses of Relative Occurences
3.4.1 Model Description
The model we ﬁt is
log
(
pijk
pij4
)
= Z
′
iα+ γj + ηk + θjk + φi,
where i = 1, . . . , 798, j = 1, . . . , 10, k = 1, 2, 3, and φi ∼ N(0, σ22), σ
−2
2 ∼
Γ(a
2
, b
2
) for a = b = 0.002.
Here Zi is the matrix containing the 5 predictor variables such as per capita
income, percentage of people below poverty level, education, epapm25 and epaso2.
The variable income, epapm25 and epaso2 were divided by 10, 000 for computational
stability. The pˆijk are the MLEs with an adjustment for zeros.
The corner point restrictions are η3 = 0, γ1 = 0, δ1k = 0, for k = 1, 2, 3,
δj3 = 0, for j = 2, . . . , 7.
We can deﬁne λijk = λijpijk and since
∑4
k=1 pijk = 1 we have
pijk =
λijk∑4
k=1 λijk
.
Thus, we take
pˆ
(t)
ijk =
λˆ
(t)
ijk∑4
k=1 λˆ
(t)
ijk
where λˆ
(t)
ijk for t = 1, . . . , 1000 are the 1000 iterates from the Metropolis-Hastings
samples.
Then, we ﬁtted the model for each iteration t = 1, . . . , 1000
log
(
pˆ
(t)
ijk
pˆ
(t)
ij4
)
= Z
′
iα
(t) + γ(t)j + η
(t)
k + θ
(t)
jk + φ
(t)
i .
Once we obtained the least square estimates we then deduce φ
(t)
i such as
φ
(t)
i =
1
3 ∗ 10
∑
j,k
{
log
(
pˆ
(t)
ijk
pˆ
(t)
ij4
)
−
(
Z
′
iα
(t) + γ(t)j + η
(t)
k + θ
(t)
jk
)}
.
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When estimates of α, γ, η, θ are obtained, we use them to obtain p
(t)
ijk again.
3.4.2 Estimates and Maps
Table 3.6 contains the mean, standard deviation and credible intervals of coeﬃcients.
Most of the covariates are signiﬁcant and the estimates are diﬀerent from the one
obtained in Chapter 2 (see Table 2.2). The intercept and income are not signiﬁcant
anymore. Epapm25 and Epaso2 are the two most signiﬁacnt covariates. The pa-
rameters accounting for age class are all signiﬁcant except for the second age class.
The estimates of the interaction between age class and disease are clearly signiﬁcant
except for colon cancer at age class 2. The parameters accounting for type of cancer
are signiﬁcant.
In Figure 3.9 we present the distribution of the proportions of deaths pijk by dis-
ease. The patterns of the box plots across age classes look similar to the one obtained
from the observed proportions in Figure 1.4.
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Figure 3.9: Distribution of the Proportions of Death by Disease
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β Mean Std Interval
Intercept 0.013 0.008 [ 0.008, 0.018]
Income -0.030 0.046 [-0.059, -0.000]
% Poverty -0.002 0.001 [-0.003, -0.002]
College 0.001 0.000 [ 0.000, 0.001]
Epapm25 -6.571 2.171 [-8.052, -5.062]
Epaso2 2.610 0.463 [ 2.279, 2.920]
γ2 0.001 0.000 [ 0.001, 0.001]
γ3 0.009 0.001 [ 0.009, 0.009]
γ4 0.065 0.002 [ 0.063, 0.066]
γ5 0.297 0.005 [ 0.293, 0.300]
γ6 0.710 0.006 [ 0.706, 0.714]
γ7 0.974 0.006 [ 0.970, 0.978]
γ8 0.986 0.005 [ 0.982, 0.989]
γ9 0.780 0.004 [ 0.777, 0.783]
γ10 0.471 0.005 [ 0.468, 0.474]
θ21 -0.012 0.002 [-0.014, -0.011]
θ31 -0.022 0.002 [-0.024, -0.020]
θ41 -0.077 0.003 [-0.079, -0.075]
θ51 -0.306 0.005 [-0.309, -0.302]
θ61 -0.696 0.007 [-0.701, -0.691]
θ71 -0.885 0.006 [-0.889, -0.881]
θ81 -0.751 0.006 [-0.754, -0.747]
θ91 -0.346 0.006 [-0.350, -0.342]
θ101 0.180 0.009 [ 0.174, 0.185]
θ22 0.001 0.001 [ 0.000, 0.002]
θ32 0.004 0.001 [ 0.004, 0.005]
θ42 -0.013 0.003 [-0.015, -0.011]
θ52 -0.179 0.005 [-0.182, -0.176]
θ62 -0.538 0.006 [-0.542, -0.534]
θ72 -0.764 0.006 [-0.767, -0.760]
θ82 -0.741 0.005 [-0.744, -0.738]
θ92 -0.495 0.004 [-0.498, -0.493]
θ102 -0.140 0.005 [-0.143, -0.136]
η1 0.013 0.002 [ 0.011, 0.014]
η2 0.006 0.001 [ 0.005, 0.006]
Table 3.6: Mean, Standard Deviation and 95% Credible Interval for the Estimates of
the Parameters
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Figures 3.10 and 3.11 show the empirical posterior densities for the 2 most sig-
niﬁcant covariates epapm25 and epaso2 and also for the variable accounting for the
variation among HSAs, φi. They do not show much departure from the normal dis-
tribution.
68
 
Figure 3.10: Frequency Histogram for Epapm25 and Epaso2 
 
 
Figure 3.11: Frequency Histogram for Φi 
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In Figures 3.12, 3.13 and 3.14 we present the maps for age speciﬁc (40, 70 and
85 and up) of the proportions of deaths by disease. The regions of Paciﬁc, Mountain
North, Mountain South and West North Central-North present a concentration of
high proportions of death for prostate cancer for people older than 65 years old and
for other cancers for age 70 and younger. The Appalachian region and the South
Atlantic-South present a concentration of high proportions of death for lung cancer
for all age classes. The concentration of high proportions of death for colon cancer is
in the North East and North Central East regions for age 70 and older.
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Fig. 3.12: Maps of the Proportions (10^-2) of Deaths for Age 40
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Fig. 3.13: Maps of the Proportions (10^-2) of Deaths for Age 70
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Fig. 3.14: Maps of the Proportions (10^-2) of Deaths for Age 85 and Above
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The maps for age 40 for prostate and colon cancer are diﬃcult to interpret since
the data are very sparse. For prostate cancer, the regions of Mountain North, West
North Central-South and East South Central concentrate the high proportions of
death. For colon cancer, the high proportions of death are concentrated in the re-
gions of Mountain South, West North Central-North and East South Central.
In Figures 3.15, 3.16, 3.17 and 3.18 we present the maps of the proportions of
deaths for high and low values of epapm25 for prostate, colon, lung and other cancer
respectively. In Figures 3.19, 3.20, 3.21 and 3.22 we present the corresponding maps
for high and low values of epaso2. The maps do not show any strong pattern. Still,
we observe that the proportion of deaths by lung cancer are high n the South Eastern
states though there are high elsewhere as well.
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Fig. 3.15: Maps of the Proportions (10^-2) of Death for Prostate Cancer for High and Low Epapm25
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Fig. 3.16: Maps of the Proportions (10^-2) of Death for Colon Cancer for High and Low Epapm25
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Fig. 3.17: Maps of the Proportions (10^-2) of Death for Lung Cancer for High and Low Epapm25
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Fig. 3.18: Maps of the Proportions (10^-2) of Death for Other Cancer for High and Low Epapm25
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Fig. 3.19: Maps of the Proportions (10^-2) of Death for Prostate Cancer for High and Low EpaSO2
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Fig. 3.20: Maps of the Proportions (10^-2) of Death for Colon Cancer for High and Low EpaSO2
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Fig. 3.21: Maps of the Proportions (10^-2) of Death for Lung Cancer for High and Low EpaSO2
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Fig. 3.22: Maps of the Proportions (10^-2) of Death for Other Cancer for High and Low EpaSO2
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3.5 Concluding Remarks
First we ﬁtted the NSP model to obtain the rates using the Metropolis-Hastings
algorithm. Then we deduced the proportions of deaths for each disease and ﬁtted a
model which is a simple extension of the one discussed in Chapter 2 by incorporating
a random eﬀect for the HSAs.
The maps for diﬀerent age classes and diseases show interesting patterns and
highlighted some hot-spots. The maps for colon and prostate cancer for age less than
40 have to be interpreted with caution because of the sparseness of the data.
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Chapter 4
Concluding Remarks
Our goals in this project are to analyze mortality rates for all types of cancer and to
estimate their relative occurrences. We use Bayesian methods.
4.1 Review of Methodology
We make inference on the mortality rates by disease in two steps. Since our model
shows that the mortality rates by disease are the product of the mortality rates for
all cancer diseases and the proportions of death by disease, a two-part model is used.
To model the rates we used the NSP model of Nandram, Sedransk and Pickle
(1999). Then we needed to develop new models for the occurrences.
Because the data are very sparse especially in the ﬁrst 4 age classes, we amalga-
mated them as follows: age classes 1,2,3,4 as group 1, 5 as group 2, 6 as group 3, . . . ,
10 as group 7.
We began by investigating the ﬁt of an approximate model for the pijk. The
parameter estimates, standard errors and maps were obtained. Unfortunately the
maps had a pattern that was similar for each age class and each disease. The model
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does not ﬁt the data well. Then we ﬁtted another approximate model. Only slight
improvements were observed. The maps did not show any interesting pattern.
Finally, we apply the model used for the λij to each disease so we got the estimates
of the λijk and then we deduce the pijk. Using Bayesian p-value and a cross-validation
exercise, we showed that this model performs well. The maps for the mortality rates
and for the relative occurrences showed diﬀerent patterns for each disease across age
classes. The maps obtained for age 40 should be interpreted with caution because of
the sparseness of the data.
4.2 Final Results
The mortality rates for each type of cancer increase with age class, of course, with
diﬀerent intensities. Prostate cancer presents the widest range of mortality rates.
The mortality rates for colon cancer increase across age classes but not as much as
prostate and lung cancer.
The maps of the mortality rates show some interesting hot spots for prostate
cancer in the North West and North Central regions. For colon cancer, the high mor-
tality rates are concentrated in the regions of the North East and east North Central.
The high mortality rates for lung cancer and all cancers are both concentrated in the
South East region for each age class. This is not surprising since lung cancer is the
leading cause of death by cancer.
The proportions of deaths for each type of cancer follow diﬀerent patterns. The
proportions of deaths increase with age class for prostate and colon cancer while it
does so for lung cancer but only until age 55 where they begin to drop. Lung cancer
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is the leading cause of cancer death across age class except for the older men (age
85 and above) for which the proportions are similar to the one for prostate cancer.
One should note that the proportions of cancer deaths by prostate cancer increase
steadily while they do so for colon cancer but slowly.
With all factors being the same, the odds of occurrences of prostate, colon and
lung with respect to others decrease (increase) substantially with epapm25 (epaSO2).
We conjecture that particulate matters in the air aﬀects mostly young people but
sulphur dioxide aﬀects mostly the elderly.
The maps of the relative occurrences for age 40 for prostate and colon cancer are
diﬃcult to interpret since the data are very sparse. For prostate cancer, the regions
of Mountain North, West North Central-South and East South Central concentrate
the high proportions of death. For colon cancer, the high proportions of death are
concentrated in the regions of Mountain South, West North Central-North and East
South Central. The regions of Paciﬁc, Mountain North, Mountain South and West
North Central-North present a concentration of high proportions of deaths for prostate
cancer for people older than 65 years old and for other cancers for age 70 and younger.
The Appalachian region and the South Atlantic-South present a concentration of high
proportions of deaths for lung cancer for all age classes. The concentration of high
proportions of deaths for colon cancer is in the North East and North Central East
regions for age 70 and older.
4.3 An Alternative Approach
We assume that dij |nij, λij
ind
∼ Poisson(nijλij). We ﬁt a hierarchical model with a
single regression coeﬃcient. The basis model for the analysis is as follows
logλij = x
′
j β + νi + δj (4.1)
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where x
′
j =
(
1, decadej, (decadej)2, (decadej)3,max{0, (decadej−knot)3}
)
with decade1 =
0.25 , decadej = j − 1 for j = 2, . . . , 10.
We assume that νi|σ21
iid
∼ N
(
0, σ21
)
, δj|σ22
iid
∼ N
(
0, σ22
)
and the value of the knot
that maximizes the likelihood of U.S. marginal data is 6 for “all cancer”.
Here, p(β) = 1 and σ−21k , σ
−2
2k ∼ Γ(
a
2
, b
2
) where a = b = 0.002 to obtain a proper
diﬀuse prior.
This can be ﬁtted easily for all cancer. If one can model the individual type of
cancer simultaneously through (4.1) the entire problem about the pijk would be solved
automatically because
pijk =
λijk
λij
such that the constraint λij =
∑
k λijk.
Better methods are needed to show variability in disease mapping over the areas.
A model like the one in Chapter 2 but exact and with a random eﬀect could incor-
porate better heterogeneity among areas. We attempted to do so already but with
little success.
The real diﬃculty is in modeling the pijk. One could add a random eﬀect in the
model so we get the mixed eﬀects model
log
(
pijk
pij4
)
= Z
′
iα+ γj + ηk + θjk + φi
where i = 1, . . . , 798, j = 1, . . . , 10, k = 1, 2, 3, Zi containing the covariates,
φi ∼ N(0, σ22), σ
−2
2 ∼ Γ(.001, .001). The corner point restrictions are η3 = 0, γ1 = 0,
θ1k = 0, for k = 1, 2, 3, θj3 = 0, for j = 2, . . . , 7.
The Metropolis-Hastings algorithm was used but with little success. Since the
estimates of the covariates contained in α were not stable, we tried using one covariate
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epapm25 and got better results. Besides that, the model was very sensitive to the
sparseness of the data for the ﬁrst four age classes so we tried to amalgamate the age
classes so 5 age classes remain. The algorithm was working better but once we had
got the estimates to move well, they were highly correlated.
It seems that the data do not permit this kind of model, but further investigation
is required to ﬁt this model.
Another aspect that would need to be addressed is to relate the variation among
HSAs for the λij and for the pijk by introducing a dependence such as(
νi
φi
)
iid
∼ N
((
0
0
)
,∆
)
.
Yet another important point would be to incorporate some spatial structure on(
νi
φi
)
. In this case one would need to delete the intercept from both models.
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Appendix A: Model for the λij
A locally uniform prior distribution is used on β for each region and a proper
diﬀuse prior on σ21 and σ
2
2 as follows
p(β) = 1 and σ21, σ
2
2 ∼ Γ(
a
2
,
b
2
) where a = b = 0.002.
To ﬁt this model, we use the Metropolis-Hastings algorithm implementing the
product of Kernels Principle (Chib and Greenberg 1995) which essentially allows us
to draw successively from each conditional posterior distribution, instead of having
to run each of the conditional posterior distribution to convergence for every value
of the conditional variables (parameters). Whenever an opportunity arises, we also
use the technique of centering (e.g. Gelfand et al. 1995) to facilitate computations.
An independent chain is used in the Metropolis-Hastings step which permits blocking.
The key idea to obtain the proposal density in any of our Metropolis steps is to use
a second order Taylor’s series expansion about a convenient point (an approximation
to the mode) for each conditional posterior distribution. Letting M = 10 and N =
798, the joint posterior density is
p(β, ν, δ, σ21, σ
2
2|d) ∝
N∏
i=1
M∏
j=1
{
e(x
′
jβ+νi+δj) dij − nij e
x
′
jβ+νi+δj
}
×
N∏
i=1
{(
1
σ21
)1/2
e
− 1
2σ21
ν2i
} M∏
j=1
{(
1
σ22
)1/2
e
− 1
2σ22
δ2j
}
×
(
1
σ21
)a/2+1
e
− b
2σ21
(
1
σ22
)a/2+1
e
− b
2σ22 .
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First of all, we make the transformation x
′
jβ + δj = φj which leads to
p(β, ν, δ, σ21, σ
2
2 |d) ∝
N∏
i=1
M∏
j=1
{
e(νi+φj) dij − nij e
νi+φj
}
×
N∏
i=1
{(
1
σ21
)1/2
e
− 1
2σ2
1
ν2i
} M∏
j=1
{(
1
σ22
)1/2
e
− 1
2σ2
2
(φj−x
′
jβ)
2
}
×
(
1
σ21
)a/2+1
e
− b
2σ21
(
1
σ22
)a/2+1
e
− b
2σ22 .
Then, we can deduce
σ−21 |β, ν, φ, σ
2
2, d ∼ Γ
(
N + a
2
,
b+
∑
i ν
2
i
2
)
(2)
σ−22 |β, ν, φ, σ
2
1, d ∼ Γ
(
M + a
2
,
b+
∑
j(φj − x
′
jβ)
2
2
)
(3)
β|ν, φ, σ21, σ
2
2, d ∼ N
((∑
j
x
∼j
x
′
j
)−1 (∑
j
φjx
∼j
)
, σ22
(∑
j
x
∼j
x
′
j
)−1)
(4)
p(φj |β, ν, σ
2
1, σ
2
2, d) ∼
∏
i
{
e(νi+φj ) dij − nij e
νi+φj
}
e
− 1
2σ2
2
(φj−x
′
jβ)
2
(5)
p(νi|β, φ, σ
2
1 , σ
2
2, d) ∼
∏
j
{
e(νi+φj ) dij − nij e
νi+φj
}
e
− 1
2σ21
ν2i
. (6)
Since the conditional posterior densities (5) and (6) are diﬃcult to work with, we
use the Metropolis algorithm in these two cases.
First, we consider conditional posterior density of φj|β, ν, σ21, σ
2
2, d. We denote ∆(φj)
the logarithm of the conditional posterior densities of φj|β, ν, σ21, σ
2
2, d such as
∆(φj) =
∑
i
{
(νi + φj) dij − nij e
νi+φj
}
−
1
2σ22
(φj − x
′
jβ)
2
= A(φj) −
1
2σ22
(φj − x
′
jβ)
2.
Then,
dA(φj)
dφj
=
∑
i
(
dij − nij e
νi+φj
)
d2A(φj)
dφ2j
= −
∑
i
nij e
νi+φj .
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Thus, based on A(φj) alone we can get an estimator of φj by setting
dA(φj )
dφj
= 0:
φˆj = log
{ ∑
i dij∑
i nije
νi
}
.
For the Metropolis step, we take
φj|β, ν, σ
2
1, σ
2
2, d
approx
∼ Uniform(a, b),
where {
a = E
(
φj|β, ν, σ21, σ
2
2, d
)
− k ∗ SD
(
φj|β, ν, σ21, σ
2
2, d
)
b = E
(
φj |β, ν, σ21, σ
2
2, d
)
+ k ∗ SD
(
φj|β, ν, σ21, σ
2
2 , d
)
.
Second, we consider how to draw ν. We denote the logarithm of the conditional
posterior distribution of νi|β, φ, σ21, σ
2
2, d by ∆(νi) where
∆(νi) =
∑
j
{
(νi + φj) dij − nij e
νi+φj
}
−
1
2σ21
νi
= A(φj)−
1
2σ21
νi.
Then,
dA(νi)
dνi
=
∑
j
(
dij − nij e
νi+φj
)
d2A(νi)
dν2i
= −
∑
j
nij e
νi+φj .
Thus, based on A(νi) alone we can get an estimator of νi by setting
dA(νi)
dνi
= 0:
νˆi = log
{ ∑
j dij∑
j nije
νi
}
and we can deduce that
νi|β, φ, σ
2
1, σ
2
2, d
approx
∼ Uniform(a, b),
where {
a = E
(
νi|β, φ, σ21, σ
2
2, d
)
− k ∗ SD
(
νi|β, φ, σ21, σ
2
2, d
)
b = E
(
νi|β, φ, σ21, σ
2
2, d
)
+ k ∗ SD
(
νi|β, φ, σ21, σ
2
2, d
)
.
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Appendix B: First Approximate Model for the pijk
Matrix Formulation of the Model
Let’s denote y
i
=

yi,1,1
yi,1,2
yi,1,3
...
yi,j,1
yi,j,2
yi,j,3
...
yi,7,1
yi,7,2
yi,7,3

, xi =
 Z
′
i
... A
Z
′
i

where A =

0 0 . . . 0 0 0 . . . 0 0 0 0 . . . 0 0 1 0
0 0 . . . 0 0 0 . . . 0 0 0 0 . . . 0 0 0 1
0 0 . . . 0 0 0 . . . 0 0 0 0 . . . 0 0 0 0
1 0 . . . 0 1 0 . . . 0 0 0 0 . . . 0 0 1 0
1 0 . . . 0 0 0 . . . 0 0 1 0 . . . 0 0 0 1
1 0 . . . 0 0 0 . . . 0 0 0 0 . . . 0 0 0 0
0 1 . . . 0 0 1 . . . 0 0 0 0 . . . 0 0 1 0
0 1 . . . 0 0 0 . . . 0 0 0 1 . . . 0 0 0 1
0 1 . . . 0 0 0 . . . 0 0 0 0 . . . 0 0 0 0
...
...
. . .
...
...
...
. . .
...
...
...
...
. . .
...
...
...
...
0 0 . . . 1 0 0 . . . 1 0 0 0 . . . 0 0 1 0
0 0 . . . 1 0 0 . . . 0 0 0 0 . . . 0 1 0 1
0 0 . . . 1 0 0 . . . 0 0 0 0 . . . 0 0 0 0

.
Then, the model can be written as
Y = Xβ + 3 where 3 ∼ N
(
0, σ2W
)
and β =
(
α
6∗1
γ2 γ3 . . . γ7 δ21 . . . δ72 η1 η2
)′
.
(7)
The weight matrix W is a block diagonal matrix of (21× 21) matrices Wi which are
themselves block diagonal matrices of (3× 3) matrices wij .
The estimators are such as
βˆ =
(
X
′
W−1X
)−1
X
′
W−1Y,
Cov
(
βˆ
)
=
(
X
′
W−1X
)−1
σˆ2,
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σˆ2 =
(
Y −Xβˆ
)′(
Y −Xβˆ
)/
(21× n− 26).
For computational purposes, we did not use matrix algebra to invert the matrices
but the following identities and transformations
X
′
W−1X =
n∑
i=1
X
′
iW
−1
i Xi and X
′
W−1Y =
n∑
i=1
X
′
iW
−1
i Yi
.
Construction of the Weights
Since we assume that the dijk’s follow a multinomial distribution such as
dij |pij
ind
∼ Multinomial(dij., pij) and pˆijk =
dijk
dij.
=⇒
pˆijk
pˆij3
=
dijk
dij3
,
then Var

pˆij1
pˆij2
pˆij3
pˆij4
 = 1dij.

pij1(1− pij1) −pij1pij2 −pij1pij3 −pij1pij4
−pij1pij2 pij2(1− pij2) −pij2pij3 −pij2pij4
−pij1pij3 −pij2pij3 pij3(1− pij3) −pij3pij4
−pij1pij4 −pij2pij4 −pij3pij4 pij4(1− pij4)

Now, let T be a vector with ﬁnite variance Σ and mean µ. Take any function
f(T ), then the ﬁrst order Taylor’s series expansion of f(T ) is
f(T ) ≈ f(µ) + (T − µ)
′
G(µ) where G(µ) is the gradient vector.
Therefore,
Var (f(T )) ≈ Var
(
(T − µ)
′
G(µ)
)
= G(µ)T Var(T ) G(µ),
and
Cov (f1(T ), f2(T )) ≈ Gf1(µ)
T Var(T ) Gf2(µ).
Our three functions are fk(p) = log pijk − log pij4 for k = 1, . . . , 3 .
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Then Var
(
fk(pˆ)
)
= 1
dij.
(
1
pijk
+ 1
pij4
)
≈ 1
dijk
+ 1
dij4
, and
Cov
(
f1(p), f2(p)
)
= Cov
(
f1(p), f3(p)
)
= Cov
(
f2(p), f3(p)
)
=
1
dij.pij4
≈
1
dij4
.
It follows that wij =

1
dij1
+ 1
dij4
1
dij4
1
dij4
1
dij4
1
dij2
+ 1
dij4
1
dij4
1
dij4
1
dij4
1
dij3
+ 1
dij4
 .
Approximations
Approximations on the responses and the weights
In order to compute log
(
pijk
pij4
)
pijk=pˆijk
= log
(
dijk
dij4
)
, i = 1, 2, 3, we used the new
deﬁnition d∗ijk of dijk
d∗ijk =
{
10−6 if dijk = 0,
dijk otherwise.
Moreover, for small dijk, Pickle et al. (1996) have shown that one will obtain
better estimates of the λij and the pijk using more stable quantities obtained which
can be obtained computing the averages by regions for small dijk’s such as
d∗∗ijk =
{ ∑
i∈R
∑10
j=1 dijk
∑
i∈R
∑10
j=1
∑
k dijk
∑
i∈R
∑
k dijk
nr
if dijk < 3,
dijk if dijk ≥ 3,
where R = region and nr = number of HSAs in the region R.
The last substitution is motivated by
∑
i∈R
∑10
j=1 dijk
∑
i∈R
∑10
j=1
∑
k dijk
≈ dijk∑
k dijk
and
∑
i∈R
∑
k dijk
nr
≈
∑
k dijk .
Methodology
After ﬁtting model (7), we can deduce the pijk’s by writing the model as follows
log(pij1
pij4
)
log(pij2
pij4
)
log(pij3
pij4
)
...
 = Xβ =

θij1
θij2
θij3
...
 ,
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where 
pij1 = eθij1/(1 + eθij1 + eθij2 + eθij3)
pij2 = eθij2/(1 + eθij1 + eθij2 + eθij3)
pij3 = eθij3/(1 + eθij1 + eθij2 + eθij3)
pij4 = 1/(1 + eθij1 + eθij2 + eθij3).
(8)
Then, we have obtained the estimates βˆ and ̂Cov
(
βˆ
)
= Σˆ and we have approxi-
mated the distribution of βˆ by
βˆ ∼ N26
(
β, Σˆ
)
.
It is convenient to use a Bayesian approach. Then by taking the non-informative
prior for β, i.e p(β) = 1, it is obvious that approximately
β|d ∼ N26
(
βˆ, Σˆ
)
. (9)
Therefore we can draw a sample of 1, 000 β’s from (9). For computational purposes,
we partitioned the parameters as follows
β
26∗1
=

β
1
10∗1
β
2
8∗1
β
3
8∗1
 and Σˆ26∗26 =

Σˆ11
10∗10
Σˆ12
10∗8
Σˆ13
10∗8
Σˆ21
8∗10
Σˆ22
8∗8
Σˆ23
8∗8
Σˆ31
8∗10
Σˆ32
8∗8
Σˆ33
8∗8
 . (10)
Then, we
i) generate β
1
using the marginal distribution β
1
|b1 ∼ N8
(
βˆ
1
, Σˆ11
)
,
ii) generate the conditional distribution of β
2
|β
1
= b1 which is normal and has the
mean
βˆ
2
+ Σˆ21Σˆ11
−1
(b1 − βˆ1),
and covariance
Σˆ22 − Σˆ21Σˆ11
−1
Σˆ12
,
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iii) and ﬁnally generate the conditional distribution of β3|β1 = b1, β2 = b2 which is
Normal and has the mean
βˆ3 + (Σˆ31, Σˆ32)
(
Σˆ11 Σˆ12
Σˆ21 Σˆ22
)−1 (
b1 − βˆ1
b2 − βˆ2
)
,
and covariance
Σˆ33 − (Σˆ31, Σˆ32)
(
Σˆ11 Σˆ12
Σˆ21 Σˆ22
)−1 (
Σˆ13
Σˆ23
)
.
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